Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Borderline Personality Disorder
- Depressive Disorder, Major
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Patients will be randomized to receive: active L-DLPFC stimulation, active DMPFC stimulation, or sham stimulation. Group size ratio will be 1:1:1.Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 22 years and 65 years
- Gender
- Both males and females
Description
We recently developed a form of neuromodulation termed Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT). This project aims to measure and modulate a mood depressive episode (MDE) in inpatients diagnosed with borderline personality disorder. We will test the antidepressant effect of S...
We recently developed a form of neuromodulation termed Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT). This project aims to measure and modulate a mood depressive episode (MDE) in inpatients diagnosed with borderline personality disorder. We will test the antidepressant effect of SAINT stimulation over the left dorsolateral prefrontal cortex (L-DLPFC) with SAINT stimulation over the dorsomedial prefrontal cortex (DMPFC) compared with sham.
Tracking Information
- NCT #
- NCT04870255
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Nolan Williams, MD Stanford University
Get Well Soon